Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

Seung, Kwonjune J., Keshavjee, Salmaan, Rich, Michael L.·2015·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a017863

Cited by (803)

Items 101–200 of 803

  1. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects
    Ahmed S. Abdelkhalek, Mohamed S. Attia, Mohammad Amjad Kamal · 2023 · Current Medicinal Chemistry
  2. MDR-TB in Pakistan: Challenges, efforts, and recommendations
    Mahad Ahmed Khan, Wajeeha Bilal, Hanzla Asim, Zainab Syyeda Rahmat, Mohammad Yasir Essar, Shoaib Ahmad · 2022 · Annals of Medicine and Surgery
  3. The Effect of Inoculum Size on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis
    Kübra Yıldırım, Cemilenur Ataş, Ece Şimşek, Ahmet Yılmaz Çoban · 2023 · Microbiology Spectrum
  4. Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
    Aynias Seid, Yilak Girma, Ayenesh Abebe, Eseye Dereb, Meseret Kassa, Nega Berhane · 2023 · Infection and Drug Resistance
  5. Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis
    Virginia Meikle, Lei Zhang, Michael Niederweis · 2023 · Antimicrobial Agents and Chemotherapy
  6. Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis
    Cong Guo Jin, Yuting Wu, Jiangpo Chen, Jing Liu, Hongwei Zhang, Qingzeng Qian, Tieliang Pang · 2024 · Journal of Global Antimicrobial Resistance
  7. In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs
    Nolwazi Thobeka Portia Ngidi, Kgothatso Eugene Machaba, Ndumiso Nhlakanipho Mhlongo · 2022 · Molecules
  8. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis
    Sapna Saini, Anjali Gangwar, Rashmi Sharma · 2023 · Microbiological Research
  9. New heterobimetallic ferrocenyl derivatives: Evaluation of their potential as prospective agents against trypanosomatid parasites and Mycobacterium tuberculosis
    Feriannys Rivas, Andrea Medeiros, Esteban Rodríguez Arce, Marcelo Alberto Comini, Camila Maríngolo Ribeiro, Fernando Rogerio Pavan, Dinorah Gambino · 2018 · Journal of Inorganic Biochemistry
  10. Pediatric Drug-resistant Tuberculosis in Madrid
    Begoña Santiago, Fernando Baquero‐Artigao, Asunción Mejías, Daniel Blázquez‐Gamero, María Soledad Jiménez, María José Mellado · 2013 · The Pediatric Infectious Disease Journal
  11. Multidrug‐resistant tuberculosis during pregnancy and adverse birth outcomes: a systematic review and meta‐analysis
    Kefyalew Addis Alene, Alemken Jegnie, Akilew Awoke Adane · 2020 · BJOG An International Journal of Obstetrics & Gynaecology
  12. A tuberculosis epidemic model as a proxy for the assessment of the novel M72/AS01E vaccine
    Dipo Aldila, Joseph Páez Chávez, Karunia Putra Wijaya, Naleen Chaminda Ganegoda, Gracia Monalisa Simorangkir, Hengki Tasman, Edy Soewono · 2023 · Communications in Nonlinear Science and Numerical Simulation
  13. Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
    Zitong Shao, Michael Y.T. Chow, Shing Fung Chow, Jenny K.W. Lam · 2023 · Pharmaceutical Research
  14. Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
    Mosayeb Rostamian, Sara Kooti, Ramin Abiri, Saeed Khazayel, Sepide Kadivarian, Soroush Borji, Amirhooshang Alvandi · 2023 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
  15. Features of 921 Patients With Spinal Tuberculosis: A 16-Year Investigation of a General Hospital in Southwest China
    Yuan Yao, Weilin Song, Kuiyou Wang, Bingtao Ma, Huan Liu, Wenjie Zheng, Yu Tang, Yue Zhou · 2017 · Orthopedics
  16. Facile green synthesis of silver nanoparticles derived from the medicinal plant Clerodendrum serratum and its biological activity against Mycobacterium species
    Vidyasagar, Ritu Raj Patel, Sudhir Kumar Singh, Deepa Dehari, Gopal Nath, Meenakshi Singh · 2024 · Heliyon
  17. Biohazard levels and biosafety protection for Mycobacterium tuberculosis strains with different virulence
    Yinghua Xu, Guozhi Wang, Miao Xu · 2020 · Biosafety and Health
  18. Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy
    Santosh Kumar Sahoo, Sarvan Maddipatla, Siva Nageswara Rao Gajula, Mohammad Naiyaz Ahmad, Grace Kaul, Srinivas Nanduri, Rajesh Sonti, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi · 2022 · Bioorganic & Medicinal Chemistry
  19. Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas
    Kusuma Sai Davuluri, Amit Kumar Singh, Ajay Vir Singh, Pooja Chaudhary, Sunil Kumar Raman, Shweta Kushwaha, Shoor Vir Singh, Devendra Singh Chauhan · 2023 · Microbiology Spectrum
  20. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis
    Ali Altharawi, Manal Abdullah Alossaimi, Mohammed Mater Alanazi, Safar M. Alqahatani, Muhammad Tahir ul Qamar · 2023 · Scientific Reports
  21. Integrative genomics would strengthen AMR understanding through ONE health approach
    Chinky Shiu Chen Liu, Rajesh Pandey · 2024 · Heliyon
  22. Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosis
    Andrew W. Simonson, Todd M. Umstead, Atip Lawanprasert, Bailey Klein, Sarah Almarzooqi, Eric Scott Halstead, Scott H. Medina · 2021 · Biomaterials
  23. Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies
    Zewei Yang, Jingjing Li, Jiawen Shen, Huiru Cao, Yuhan Wang, Shanshan Hu, Yulu Du, Yange Wang, Zhongyi Yan, Longxiang Xie et al. · 2025 · Frontiers in Cellular and Infection Microbiology
  24. Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
    Tamara Akpobolokemi, Rocío T. Martínez-Nuñez, Bahijja Tolulope Raimi‐Abraham · 2022 · The Journal of Medicine Access
  25. Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations
    Jibran Sualeh Muhammad, Naveed Ahmed Khan, Sutherland Kester Maciver, Ahmad M. Alharbi, Hasan H. Alfahemi, Ruqaiyyah Siddiqui · 2022 · Antibiotics
  26. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments
    Simpal Kumar Suman, Natarajan Chandrasekaran, C. George Priya Doss · 2023 · Clinical Microbiology Reviews
  27. Breaking barriers: The potential of nanosystems in antituberculosis therapy
    Christian Shleider Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, Cesar Augusto Roque‐Borda, Giulia Polinário, Rufo Figueroa-Banda, Rafael Miguel Sábio, Marlus Chorilli, Hélder A. Santos, Fernando Rogerio Pavan · 2024 · Bioactive Materials
  28. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion
    Eleanor S. Click, Ekaterina V. Kurbatova, Heather L. Alexander, Tracy L. Dalton, Michael P. Chen, James E. Posey, Julia V. Ershova, J. Peter Cegielski · 2020 · The Journal of Infectious Diseases
  29. In-vitro and ex-vivo characterization of novel mannosylated gelatin nanoparticles of linezolid by quality-by-design approach
    Kiran Dayaram Patil, Shashikant B. Bagade, Smita Bonde · 2020 · Journal of Drug Delivery Science and Technology
  30. Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives
    Bhaiyyasaheb Harale, Saqib Kidwai, Divya Ojha, Manisha Singh, Dwarika Kumar Chouhan, Ramandeep Singh, Vijay M. Khedkar, Ambadas B. Rode · 2021 · Bioorganic & Medicinal Chemistry Letters
  31. The biofilm formation and antibiotic resistance of bacterial profile from endotracheal tube of patients admitted to intensive care unit in southwest of Iran
    Zahra Dargahi, Anas Abdullah Hamad, Ahmad Farajzadeh Sheikh, Nazanin Ahmad Khosravi, Shahla Samei Fard, Moloudsadat Motahar, Fatemeh Jahangiri Mehr, Fariba Abbasi, Hossein Meghdadi, Pejman Bakhtiyariniya et al. · 2022 · PLoS ONE · Retracted
  32. Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis
    Abdalrahman Khalifa, Amira I. Khalil, Marwa M. Abdel‐Aziz, Amgad Albohy, Samy Mohamady · 2023 · Bioorganic Chemistry
  33. Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?
    Meekha George, Rabah Boukherroub, Amitav Sanyal, Sabine Szunerits · 2025 · Materials Today Bio
  34. EspR promotes mycobacteria survival in macrophages by inhibiting MyD88 mediated inflammation and apoptosis
    Chunyan Jin, Xiaoyu Wu, Chunsheng Dong, Fengge Li, Lingbo Fan, Sidong Xiong, Yuanshu Dong · 2019 · Tuberculosis
  35. Protein synthesis in Mycobacterium tuberculosis as a potential target for therapeutic interventions
    Niraj Kumar, Shivani Sharma, Prem Singh Kaushal · 2021 · Molecular Aspects of Medicine
  36. Bag it, tag it: ubiquitin ligases and host resistance to Mycobacterium tuberculosis
    Priscila Carneiro Campos, Danielle Tahis Da Cunha, Luiz Pedro Souza‐Costa, Michael U. Shiloh, Luis H. Franco · 2022 · Trends in Microbiology
  37. Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
    Freja Breth Holmgaard, Lorenzo Guglielmetti, Troels Lillebæk, Åse Bengård Andersen, Christian Morberg Wejse, Victor Næstholt Dahl · 2022 · Clinical Infectious Diseases
  38. Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study
    Lecai Ji, Peierdun Mijiti, Hong Chuangyue, Gao Qian, Tan Weiguo, Chen Jihong · 2023 · Frontiers in Public Health
  39. Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
    Xudong Ouyang, Xiaotian Li, Jinmiao Song, Hui Wang, Shuxian Wang, Fang Ren, Zhaoli Li, Ningning Song · 2023 · Frontiers in Microbiology
  40. A Brief History of Antimicrobial Resistance
    Devin Hunt, Olivia S. Kates · 2024 · The AMA Journal of Ethic
  41. Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape
    Meghana N. Patel, Archita J. Patel, Manish N. Nandpal, Manan Raval, Ravish J. Patel, Amit A. Patel, Keshav Raj Paudel, Philip M. Hansbro, Sachin Kumar Singh, Gaurav Gupta et al. · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  42. Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells
    John Blischak, Ludovic Tailleux, Marsha Myrthil, Cécile Charlois-Ou, Emmanuel Bergot, Aurélien Dinh, Gloria Morizot, Olivia Chény, Cassandre Von Platen, Jean‐Louis Herrmann et al. · 2017 · Scientific Reports
  43. Genome-Wide Transcriptional Response of Mycobacterium smegmatis MC2155 to G-Quadruplex Ligands BRACO-19 and TMPyP4
    Egor A. Shitikov, Dmitry Bespiatykh, Maja V. Malakhova, Julia Bespyatykh, Ivan N. Bodoev, Tatiana Vedekhina, Marina V. Zaychikova, Vladimir A. Veselovsky, Ksenia M. Klimina, Elena Nikolaevna Ilina et al. · 2022 · Frontiers in Microbiology
  44. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia
    Getu Diriba, Abebaw Kebede, Habteyes Hailu Tola, Bazezew Yenew, Shewki Moga, Desalegn Addise, Ayinalem Alemu, Zemedu Mohammed, Muluwork Getahun, Mengistu Fantahun et al. · 2020 · PLoS ONE
  45. Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates
    Wei Zhou, Bing Yang, Yanyan Zou, Khaista Rahman, Xiaojian Cao, Yingying Lei, Ren Lai, Zhen Fang Fu, Xi Chen, Gang Cao · 2021 · Frontiers in Microbiology
  46. Identifying RO9021 as a Potential Inhibitor of PknG from Mycobacterium tuberculosis : Combinative Computational and In Vitro Studies
    Alicia Arica-Sosa, Roberto Alcántara, Gabriel Jiménez-Avalos, Mirko Zimic, Pohl Milón, Miguel Quiliano · 2022 · ACS Omega
  47. HupB, a nucleoid-associated protein, is critical for survival of Mycobacterium tuberculosis under host-mediated stresses and for enhanced tolerance to key first-line antibiotics
    Niti Singh, Nishant Sharma, Padam Singh, Manitosh Pandey, Mohd Ilyas, Lovely Sisodiya, Tejaswini Choudhury, Tannu Priya Gosain, Ramandeep Singh, Krishnamohan Atmakuri · 2022 · Frontiers in Microbiology
  48. Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU/EEA countries between 2016 and 2021
    Piotr Serwacki, Mateusz Gajda, Wioletta Świątek – Kwapniewska, Marta Zofia Wałaszek, Karolina Nowak, Jadwiga Wójkowska‐Mach · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  49. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling
    Asmaa F. Kassem, Ahmed Sabt, Małgorzata Korycka‐Machała, Moataz Ahmed Shaldam, Malwina Kawka, Bozena R. Dziadek, Magdalena Kuzioła, Jarosław Dziadek, Rasha Z. Batran · 2024 · Bioorganic Chemistry
  50. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
    David Patrick Kateete, Rogers Kamulegeya, Edgar Kigozi, Fred Ashaba Katabazi, Deus Lukoye, Ireneaus Sebit Sindani, Hergeye Abdi, Peter Arube, George William Kasule, Kenneth Musisi et al. · 2019 · BMC Pulmonary Medicine
  51. Acetyleugenol from Acacia nilotica (L.) Exhibits a Strong Antibacterial Activity and Its Phenyl and Indole Analogues Show a Promising Anti-TB Potential Targeting PknE/B Protein Kinases
    Abubakar Abdulhamid, Talal Ahmed Awad, Abdallah Elssir Ahmed, F. Koua, Amar Mohamed Ismail · 2021 · Microbiology Research
  52. Host and Bacterial Iron Homeostasis, an Underexplored Area in Tuberculosis Biomarker Research
    Lucinda Baatjies, Andre Gareth Loxton, Monique J. Williams · 2021 · Frontiers in Immunology
  53. Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance
    Akhil Sharma, Vikas Sharma, Shivika Sharma, Sonu Sharma, Mohit Sharma, Iyyakkannu Sivanesan · 2025 · Pharmaceutics
  54. In-Silico Tool for Predicting, Scanning, and Designing Defensins
    Dilraj Kaur, Sumeet Patiyal, Chakit Arora, Ritesh Singh, Gaurav Lodhi, Gajendra P. S. Raghava · 2021 · Frontiers in Immunology
  55. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis
    Lakshmi Mounika Kelam, Mushtaq Ahmad Wani, Devendra Kumar Dhaked · 2023 · Progress in Biophysics and Molecular Biology
  56. Host-directed therapy against tuberculosis: Concept and recent developments
    Sonakshi Udinia, Mrutyunjay Suar, Dhiraj Kumar · 2023 · Journal of Biosciences
  57. Current strategies to treat tuberculosis
    Anthony T. Podany, Susan Swindells · 2016 · F1000Research
  58. Factors influencing completion of treatment among pulmonary tuberculosis patients
    Xue-Hui Fang, Yi‐Lin Dan, Jie Liu, Lei Jun, Zhiping Zhang, Xiao-Hong Kan, Dongchun Ma, Guo‐Cui Wu · 2019 · Patient Preference and Adherence
  59. Cascade of deoxyribozymes for the colorimetric analysis of drug resistance in Mycobacterium tuberculosis
    B. Dhar, Adam J. Reed, Suvra Mitra, Patricia Rodriguez Sanchez, Daria D. Nedorezova, Ryan P. Connelly, Kyle H. Rohde, Yulia V. Gerasimova · 2020 · Biosensors and Bioelectronics
  60. Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia
    Tesfaye Andualem, Dereje K. Belayneh · 2021 · Infection and Drug Resistance
  61. Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis
    Getu Diriba, Habteyes Hailu Tola, Ayinalem Alemu, Bazezew Yenew, Dinka Fikadu Gamtesa, Abebaw Kebede · 2021 · PLoS ONE
  62. CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice
    Vipul Kumar Singh, Eric P. Chau, Abhishek Mishra, Alexandro DeAnda, Venkatesh L. Hegde, K. Jagannadha Sastry, David Haviland, Chinnaswamy Jagannath, Biana Godin, Arshad Khan · 2022 · Journal of Controlled Release
  63. Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV/Mtb Co-Infection Studies
    Madeleine Lepard, Jack X. Yang, Sam Afkhami, Aisha Nazli, Anna Zganiacz, Shangguo Tang, Margaret Wa Yan Choi, Fatemah Vahedi, Alexandre Deshière, Michel J. Tremblay et al. · 2022 · Viruses
  64. Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?
    Nikhat Khan, Aparup Das · 2020 · Precision Clinical Medicine
  65. Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
    Nala Kachour, Abrianna Beever, James Owens, Ruoqiong Cao, Afsal Kolloli, Ranjeet Kumar, Kayvan Sasaninia, Charles Vaughn, Mohkam Singh, Edward Truong et al. · 2022 · Antioxidants
  66. The second national anti‐tuberculosis drug resistance survey in Tanzania, 2017–2018
    Beatrice Kemilembe Mutayoba, Julia V. Ershova, Eligius Lyamuya, Michael Höelscher, Norbert Heinrich, Andrew Martin Kilale, Nyagosya Segere Range, Bernard James Ngowi, Nyanda Elias Ntinginya, Saidi Mwinjuma Mfaume et al. · 2022 · Tropical Medicine & International Health
  67. Potential of African flora to combat tuberculosis and drug resistance of Mycobacteria: Rationale classification of antimycobacterial agents from a natural source
    Cedric Fossi Tchinda, Victor Kuete · 2022 · Advances in botanical research
  68. Multi-drug loaded eugenol-based nanoemulsions for enhanced anti-mycobacterial activity
    Parvathy Mohan Menon, Natarajan Chandrasekaran, C. George Priya Doss, Sivakumar Shanmugam · 2023 · RSC Medicinal Chemistry
  69. A Comprehensive Review on Long vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT)
    Ashwin Karnan, Ulhas S. Jadhav, Babaji Ghewade, Anjana Ledwani, Poorna Shivashankar · 2024 · Cureus
  70. Advancements in Artificial Intelligence for the Diagnosis of Multidrug Resistance and Extensively Drug-Resistant Tuberculosis: A Comprehensive Review
    Shanmuga Priya K, Anbumaran Parivakkam Mani, S Geethalakshmi, Sankalp Yadav · 2024 · Cureus
  71. The Molecular Mechanisms and Therapeutic Potential of Cranberry, D-Mannose, and Flavonoids against Infectious Diseases: The Example of Urinary Tract Infections
    Πέτρος Ιωάννου, Stella Baliou · 2024 · Antibiotics
  72. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives
    Shahinda S. R. Alsayed, Shichun Lun, Alan D. Payne, William R. Bishai, Hendra Gunosewoyo · 2021 · Chemical Biology & Drug Design
  73. Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus
    Niccolò Riccardi, Agostina Pontarelli, Riccardo Alagna, Laura Saderi, Maurizio Ferrarese, Paola Francesca Castellotti, Pietro Viggiani, Daniela María Cirillo, Giorgio Besozzi, Giovanni Sotgiu et al. · 2020 · Public Health
  74. Synthetic Biology-Based Approaches to Investigate Host–Pathogen Interactions
    Rajdeep Banerjee · 2025 · SynBio
  75. Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis
    Elizabeth Annie George, Aniket Naha, H. Soundharya, Janardhan Pallavi, Anushka Menon, Anand Anbarasu, Sudha Ramaiah · 2025 · Probiotics and Antimicrobial Proteins
  76. Indole Fused Benzimidazole Hybrids: A Promising Combination to Fulfill Pharmacological Significance
    Rachana Upadhyay, Zebabanu Khalifa, Amit B. Patel · 2022 · Polycyclic aromatic compounds
  77. Solid Lipid Nanoparticles in Tuberculosis
    Dhwani Rana, Sagar Salave, Ritu Prabha Patel, Dignesh Khunt, Manju Misra, Bhupendra Gopalbhai Prajapati, Geeta K. Patel, Jayvadan K. Patel · 2023 · Springer eBooks
  78. Chalcones as Anti-Infective Agents for Effective Management of Tuberculosis
    Shweta Mishra, Pradip Jana · 2023 · Polycyclic aromatic compounds
  79. Synthesis and characterization of magnetic molecularly imprinted polymers for the rapid and selective determination of clofazimine in blood plasma samples
    Nur Masyithah Zamruddin, Herman Herman, Saliza Binti Asman, Aliya Nur Hasanah · 2024 · Heliyon
  80. Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study
    Tilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, Eyman Mohamed Eltayib, Abualgasim Elgaili Abdalla · 2025 · Frontiers in Chemistry
  81. Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran
    B. Motavaf, N. Keshavarz, F. Ghorbanian, S. Firuzabadi, Farzaneh Hosseini, S Zaker Bostanabad · 2021 · New Microbes and New Infections
  82. High miRNA-378 expression has high diagnostic values for pulmonary tuberculosis and predicts adverse outcomes
    Xiaolu Sun, Kai Liu, Yan Zhao, Tianhua Zhang · 2022 · BMC Molecular and Cell Biology
  83. Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents
    Moksh Shah, Iva Patel, Pratik Khona, Harnisha Patel, Mange Ram Yadav, Afzal Nagani · 2025 · Scientific Reports
  84. Molecular docking-based interactions in QSAR studies on Mycobacterium tuberculosis ATP synthase inhibitors
    Sarfaraz Ahmed, Arulsamy Elphine Prabahar, Anil Kumar Saxena · 2022 · SAR and QSAR in environmental research
  85. Differential gene expression analysis combined with molecular dynamics simulation study to elucidate the novel potential biomarker involved in pulmonary TB
    Santhiya Panchalingam, K. Govindaraju, Manikandan Jayaraman, Rajalakshmi Kumar, Santhiya Kalimuthu, Jeyaraman Jeyakanthan · 2023 · Microbial Pathogenesis
  86. Mitigation of Antimicrobial Resistance (AMR) in G20
    Aniket Shevade, Shambhavi Naik · 2023 · Indian Public Policy Review
  87. Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis
    Tomayo I. Berida, Samuel R. McKee, Shamba Chatterjee, Destinee L. Manning, Wei Li, Pankaj Pandey, Siddharth Tripathi, Yassin Mreyoud, Asya Smirnov, Robert J. Doerksen et al. · 2023 · ACS Infectious Diseases
  88. Mycobacterium tuberculosis Sub-Lineage 4.2.2/SIT149 as Dominant Drug-Resistant Clade in Northwest Ethiopia 2020–2022: In-silico Whole-Genome Sequence Analysis
    Daniel Shitu Mekonnen, Abaineh Munshea, Endalkachew Nibret, Bethlehem Adnew, Hailu Getachew, Amiro Kebede, Ananya Gebrewahid, Silvia Herrera-León, Arancha Amor, Agustín Benito et al. · 2023 · Infection and Drug Resistance
  89. Recent Advances in Nanotechnology-Based Strategies for Bone Tuberculosis Management
    Yuanrui Luo, Hongwei Chen, Hua Chen, Peng Xiu, Jiancheng Zeng, Yueming Song, Tao Li · 2024 · Pharmaceuticals
  90. Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings
    David B. Olawade, Judith Eberhardt, Aanuoluwapo Clement David-Olawade, Malik A. Balogun, Obasanjo Afolabi Bolarinwa, Deborah Tolulope Esan · 2024 · Health Sciences Review
  91. Investigation of the antimycobacterial activity of African medicinal plants combined with chemometric analysis to identify potential leads
    Phanankosi Moyo, Michael Ofori, Olusola Bodede, Madelien Wooding, Ndivhuwo Kevin Khorommbi, Lyndy Joy McGaw, Cynthia Amaning Danquah, Vinesh Jaichand Maharaj · 2024 · Scientific Reports
  92. Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis
    Manaswini Jagadeb, Kali Prasad Pattanaik, Surya Narayan Rath, Avinash Sonawane · 2020 · Computers in Biology and Medicine
  93. In-vitro Anti-Tuberculosis, Anti-Efflux Pumps and Anti-Biofilm Effects of Crinum Asiaticum Bulbs
    Michael Ofori, Cynthia Amaning Danquah, Selase Ativui, Peace Doe, Williams Adu Asamoah · 2021 · Biomedical & Pharmacology Journal
  94. Trends and Progress on Antibiotic‐Resistant Mycobacterium tuberculosis and Genes in relation to Human Immunodeficiency Virus
    Nokhanyo Gloria Mbewana Ntshanka, Titus A.M. Msagati · 2023 · Canadian Journal of Infectious Diseases and Medical Microbiology
  95. Exploration of 5‐(5‐nitrothiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazoles as selective, multitargeted antimycobacterial agents
    Neha Agre, Mihir Khambete, Arundhati Maitra, Antima Gupta, Tulika Munshi, Sanjib Bhakta, Mariam Sohel Degani · 2019 · Chemical Biology & Drug Design
  96. In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis
    Chi Zhang, Qi Ouyang, Xianyuan Zhou, Yingfeng Huang, Yu Zeng, Li Fei Deng, Dachuan Lin, Weidong Zheng · 2023 · Tuberculosis
  97. Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia
    Joseph Yamweka Chizimu, Eddie Samuneti Solo, Precious Bwalya, Thoko Flav Kapalamula, Kaemba Kunkuta Mwale, David Squarre, Misheck Shawa, Patrick Lungu, David Atomanyi Barnes, Kaunda Yamba et al. · 2023 · Antibiotics
  98. Risk factors of MDR-TB and impacts of COVID-19 pandemic on escalating of MDR-TB incidence in lower-middle-income countries: A scoping review
    Ichsan Ichsan, Lynda J Redwood-Campbell, Nissa N. Mahmud, Herlina Dimiati, Muhammad Turhan Yani, Mudatsir Mudatsir, Maimun Syukri · 2023 · Narra J
  99. Design, synthesis and docking studies of new molecular hybrids bearing benzimidazole and thiazolidine-2,4-dione as potential antitubercular agents
    Madihalli Srinivas Raghu, Amar Yasser Jassim, Chikkur B. Pradeep Kumar, Kumarswamy Yogesh Kumar, M.K. Prashanth, Fahd Alharethy, Byong‐Hun Jeon · 2024 · Journal of the Indian Chemical Society
  100. A trans -Translation Inhibitor is Potentiated by Zinc and Kills Mycobacterium tuberculosis and Nontuberculous Mycobacteria
    Akanksha Varshney, Ziyi Jia, Michael D. Howe, Kenneth C. Keiler, Anthony D. Baughn · 2025 · ACS Infectious Diseases